Eicosapentaenoic acid prevents saturated fatty acid-induced vascular endothelial dysfunction: Involvement of long-chain acyl-CoA synthetase

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 11, 2015, Pages 1172-1185

  Ishida, Takayuki ^a   Naoe, Satoko ^a   Nakakuki, Masanori ^a   Kawano, Hiroyuki ^a   Imada, Kazunori ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Eicosapentaenoic acid; Long chain acyl CoA Synthetase; Saturated fatty acid; Vascular endothelial cell

Indexed keywords

CELL ADHESION MOLECULE; CERAMIDE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; I KAPPA B; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LONG CHAIN FATTY ACID COENZYME A LIGASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PALMITIC ACID; PENTRAXIN 3; PROTEIN P21; SYNAPTOTAGMIN I; COENZYME A LIGASE; LONG-CHAIN-FATTY-ACID-COA LIGASE; PALMITIC ACID DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

BLOTTING, WESTERN; CELLS, CULTURED; COENZYME A LIGASES; CYTOKINES; EICOSAPENTAENOIC ACID; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PALMITIC ACIDS; PHOSPHORYLATION;

EID: 84939554136     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.28167     Document Type: Article

References (34)

1. Boden G: Obesity and free fatty acids (FFA). Endocrinol Metab Clin North Am, 2008; 37: 635-646
2. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes, 1988; 37: 1020-1024
3. Carlsson M, Wessman Y, Almgren P, Groop L: High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol, 2000; 20: 1588-1594
4. Imrie H, Abbas A, Kearney M: Insulin resistance, lipotoxicity and endothelial dysfunction. Biochim Biophys Acta, 2010; 1801: 320-326
5. Prieur X, Rőszer T, Ricote M: Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta, 2010; 1801: 327-337
6. Chapman MJ, Sposito AC: Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther, 2008; 117: 354-373
7. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 2007; 369: 1090-1098
8. Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis, 2008; 200: 135-140
9. Libby P, Okamoto Y, Rocha VZ, Folco E: Inflammation in atherosclerosis: transition from theory to practice. Circ J, 2010; 74: 213-220
10. Estadella D, da Penha Oller do Nascimento CM, Oyama LM, Ribeiro EB, Dâmaso AR, de Piano A: Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm, 2013; 2013: 137579
11. Nakakuki M, Kawano H, Notsu T, Imada K: Eicosapentaenoic acid suppresses palmitate-induced cytokine production by modulating long-chain acyl-CoA synthetase 1 expression in human THP-1 macrophages. Atherosclerosis, 2013; 227: 289-296
12. Kageyama A, Matsui H, Ohta M, Sambuichi K, Kawano H, Notsu T, Imada K, Yokoyama T, Kurabayashi M: Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-κB, novel targets of eicosapentaenoic acid. PLoS One, 2013; 8: e68197
13. Mudau M, Genis A, Lochner A, Strijdom H: Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr, 2012; 23: 222-231
14. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F: Activation of NF-κB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol, 2009; 29: 1370-1375
15. Schwartz EA, Zhang WY, Karnik SK, Borwege S, Anand VR, Laine PS, Su Y, Reaven PD: Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol, 2010; 30: 802-808
16. Katsume A, Okigaki M, Matsui A, Che J, Adachi Y, Kishita E, Yamaguchi S, Ikeda K, Ueyama T, Matoba S, Yamada H, Matsubara H: Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system. Arterioscler Thromb Vasc Biol, 2011; 31: 1084-1092
17. Lee JY, Sohn KH, Rhee SH, Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem, 2001; 276: 16683-16689
18. Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH: Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol, 2005; 174: 5390-5397
19. Ishikado A, Nishio Y, Yamane K, Mukose A, Morino K, Murakami Y, Sekine O, Makino T, Maegawa H, Kashiwagi A: Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells. Atherosclerosis, 2009; 205: 404-412
20. Håversen L, Danielsson KN, Fogelstrand L, Wiklund O: Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis, 2009; 202: 382-393
21. Keogh JB, Grieger JA, Noakes M, Clifton PM: Flowmediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol, 2005; 25: 1274-1279
22. Tsuchiya K, Nakayama C, Iwashima F, Sakai H, Izumiyama H, Doi M, Hirata Y: Advanced endothelial dysfunction in diabetic patients with multiple risk factors; importance of insulin resistance. J Atheroscler Thromb, 2007; 14: 303-309
23. Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y: In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol, 2008; 28: 2173-2179
24. Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi M, Marfisi RM, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R: Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality. Am Heart J, 2013; 165: 208-215
25. Mashek DG, Bornfeldt KE, Coleman RA, Berger J, Bernlohr DA, Black P, DiRusso CC, Farber SA, Guo W, Hashimoto N, Khodiyar V, Kuypers FA, Maltais LJ, Nebert DW, Renieri A, Schaffer JE, Stahl A, Watkins PA, Vasiliou V, Yamamoto TT: Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res, 2004; 45: 1958-1961
26. Soupene E, and Kuypers FA: Mammalian long-chain acyl- CoA synthetases. Exp Biol Med, 2008; 233: 507-521
27. Matsuda D, Namatame I, Ohshiro T, Ishibashi S, Ōmura S, Tomoda H: Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor. J Antibiot, 2008; 61: 318-321
28. Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan- Giri A, Vickery T, Li LO, Becker L, Yuan W, Chait A, Braun KR, Potter-Perigo S, Sanda S, Wight TN, Pennathur S, Serhan CN, Heinecke JW, Coleman RA, Bornfeldt KE: Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A, 2012; 109: E715-E724
29. Li X, Gonzalez O, Shen X, Barnhart S, Kramer F, Kanter JE, Vivekanandan-Giri A, Tsuchiya K, Handa P, Pennathur S, Kim F, Coleman RA, Schaffer JE, Bornfeldt KE: Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment. Arterioscler Thromb Vasc Biol, 2013; 33: 232-240
30. Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L, Xingxuan H, Schuchman EH, Feng L, Han-Song X, An-Hua L: Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monit, 2009; 15: BR254-BR261
31. Merched AJ, Chan L: Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation, 2004; 110: 3830-3841
32. Chung YW, Jeong DW, Won JY, Choi EJ, Choi YH, Kim IY: H2O2-induced AP-1 activation and its effect on p21WAF1/CIP1-mediated G2/M arrest in a p53-deficient human lung cancer cell. Biochem Biophys Res Commun, 2002; 293: 1248-1253
33. Jung YS, Qian Y, Chen X: Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal, 2010; 22: 1003-1012
34. Zhao Y, Chen LH: Eicosapentaenoic acid prevents lipopolysaccharide- stimulated DNA binding of activator protein- 1 and c-Jun N-terminal kinase activity. J Nutr Biochem, 2005; 16: 78-84